2 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow vofopitant: new trials by email Literature Review of vofopitant trials Research Report on vofopitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects Placebo, Vofopitant, Lamotrigine - Bipolar Disorder | Phase 1 | Terminated | GlaxoSmithKline | 12 | 2009-05-15 | 2017-07-21 |
| A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia GR205171, GW597599 - Sleep Initiation and Maintenance Disorders | Phase 2 | Completed | GlaxoSmithKline | 51 | 2007-12-19 | 2017-07-11 |
| Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder NK1 Antagoist (GR205171), Psychophysiology (Trauma Script), Psychophysiology (Verbal Threat) - PTSD | Phase 2 | Completed | Baylor College of Medicine | 47 | 2006-09-01 | 2019-07-31 |
Bipolar Disorder (1) · Sleep Initiation and Maintenance Disorders (1) · Stress Disorders, Post-Traumatic (1)
GlaxoSmithKline (2) · Baylor College of Medicine (1)
Germany (2) · United States (1)